Articles related to Cardiology

A study published in the Cleveland Clinic Journal of Medicine puts forward a new and systematic approach to diagnosing and managing orthostatic hypotension. The article notes that current approaches to evaluating and managing the disease are based on limited data, but that patients would benefit from more consistent diagnosis and treatment methods.

Thinking of starting the new year off with a diet? According to U.S. News and World Report, the Mediterranean diet is the best overall diet for adults. The diet was ranked first in the categories of best diets for healthy eating, easiest diets to follow, and best diets for diabetes, among other measurable categories.

In this clinical trial, the authors attempt to answer the question of whether a high-intensity interval training program can improve cardiorespiratory fitness and delay the biochemical progression of prostate cancer in patients who are undergoing active surveillance. One group was asked to complete 12 weeks of thrice-weekly, supervised aerobic sessions on a treadmill at 85% to 95% of peak oxygen consumption (V̇o2). The usual care group maintained their normal exercise levels.

From the American Red Cross to volunteering overseas, there are plenty of feel-good “enlistments” out there for the practicing or retired physician, which can help ward off boredom and burnout while adding the benefit of perhaps learning a new skill or meeting new people. Whether your goals are short-term or you’re in for the long haul, here are nine opportunities to help humanity and feel good about the part you’re playing in the world.

Amy Watson became famous for coining the term “COVID long hauler” to describe people, such as herself, who suffer from the effects of the respiratory disease over an extended period. These long-haul symptoms can include fever, body aches, and fatigue. Watson herself says she rarely goes more than a few hours without suffering a fever, nearly two years after first contracting COVID-19. GoodRx Health chronicles Amy Watson’s story and what it’s like for people suffering from long COVID.

At the outset of the pandemic, biotechnology company Novavax was one of the frontrunners to bring a vaccine against COVID-19 to market. But nearly two years later, Novavax’s vaccine has yet to appear. In a compelling article, the BMJ details the repeated delays and setbacks that have torpedoed Novavax’s once-promising vaccine candidate and rendered it unnecessary now that other vaccines from Pfizer, Moderna, and AstraZeneca flood the global marketplace.